Femasys Inc (FEMY NASDAQ) stock market data APIs
$1.9818
0.04(2%)
as of October 7, 2026
Try our APIs with
free plan!
Femasys Inc Financial Data Overview
Price chart is built with
Anychart
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Prev. Close
1.9818
Open
2.0212
High
2.0311
Low
1.972
52 wk Range
1.96-22.2
Market Cap
17 420 K
Shares Outstanding
8 375 K
Revenue
2 299 K
EPS
-1.33
Beta
-2.155
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Femasys Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Femasys Inc data using free add-ons & libraries
Get Femasys Inc Fundamental Data
Femasys Inc Fundamental data includes:
- Net Revenue: 2 299 K
- EBITDA: -17 229 926
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -1.4
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Femasys Inc News
New
Femasys Enters $30 Mln Private Placement; Up To $90 Mln Potential Proceeds; Stock Down
(RTTNews) - Femasys Inc. (FEMY) announced that it has entered into a securities purchase agreement for a $30 million private placement of shares and warrants led by Nantahala Capital. Under the terms...
Top Biotech Gainers: WGRX Rebrands, PVLA Nears FDA Milestone, ASBP On Track For NDA Filing
(RTTNews) - Today's top biotech gainers include Wellgistics following its rebranding, Femasys, which recently resolved its Nasdaq compliance issue, Vor Bio with continued progress in its Telitacicept ...
Femasys Regains Nasdaq Compliance, Focuses On Reproductive Health Pipeline
(RTTNews) - Femasys Inc. (FEMY) announced it has regained compliance with Nasdaq's minimum bid price requirement, closing the matter with regulators and securing continued listing status. Chief Execu...
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
Key Points Dauntless Investment Group bought 116,863 shares of Innoviva in an estimated trade of $2.52 million last quarter. The quarter-end position value rose by $2.74 million, reflecting both trad...
Get Femasys Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.